CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
CVS Health (CVS) Tops Q4 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
February 10, 2026 6:31 AM ESTCVS Health (NYSE: CVS) reported Q4 EPS of $1.09, $0.09 better than the analyst estimate of $1.00. Revenue for the quarter came in at $105.7 billion versus the consensus estimate of $103.63 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.00-$7.20, versus the consensus of... More
